1 Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA), Vienna, Austria claudia.wild@hta.lbg.ac.at.
2 Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA), Vienna, Austria.
3 Independent Pharmaceutical Consultant, Mellieha, Malta.
4 Department of Finance, University of Vienna, Austria.
5 Medicinal Products Department, Health Insurance Institute of Slovenia, Ljubljana, Slovenia.
6 Medicines Reimbursement Department, National Health Insurance Fund, Vilnius, Lithuania.
7 Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
8 Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
9 Faculty of Medicine, Department of Pathology, Forensic Medicine and Pharmacology, Vilnius University and State Medicines Control Agency, Vilnius, Lithuania.
10 Healthcare Improvement Scotland, Scottish Medicine Consortium, Glasgow, UK.
11 Agency for Health Technology Assessment and Tariff System, Warsaw, Poland.